| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.0076 | 0.8 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.018 | 0.8 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K42260513 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.8 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.8 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | BRD-K80183349 | CTRPv2 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.0078 | 0.8 |